Costantino Ricci,
Maria Sirolli,
Francesca Ambrosi,
Tania Franceschini,
Francesca Giunchi,
Federico Mineo Bianchi,
Riccardo Schiavina,
francesco Massari,
Veronica Mollica,
Michelangelo Fiorentino,
Thais Maloberti,
Giovanni Tallini,
Dario de Biase, Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney, in: 2023 USCAP Annual Meeting Abstracts, 2023, pp. 247 - 247 (atti di: 2023 USCAP Annual Meeting, New Orleans Ernest N. Morial Convention Center, 11-16 Marzo 2023) [Abstract]
Antonarakis, Emmanuel S; Park, Se Hoon; Goh, Jeffrey C; Shin, Sang Joon; Lee, Jae Lyun; Mehra, Niven; McDermott, Ray; Sala-Gonzalez, Núria; Fong, Peter C; Greil, Richard; Retz, Margitta; Sade, Juan Pablo; Yanez, Patricio; Huang, Yi-Hsiu; Begbie, Stephen D; Gafanov, Rustem Airatovich; De Santis, Maria; Rosenbaum, Eli; Kolinsky, Michael P; Rey, Felipe; Chiu, Kun-Yuan; Roubaud, Guilhem; Kramer, Gero; Sumitomo, Makoto; Massari, Francesco; Suzuki, Hiroyoshi; Qiu, Ping; Zhang, Jinchun; Kim, Jeri; Poehlein, Christian H; Yu, Evan Y, Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial, «JOURNAL OF CLINICAL ONCOLOGY», 2023, 41, pp. 3839 - 3859 [Scientific article]Open Access
Matteo Rosellini; Andrea Marchetti; Veronica Mollica; Alessandro Rizzo; Matteo Santoni; Francesco Massari, Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma, «NATURE REVIEWS. UROLOGY», 2023, 20, pp. 133 - 157 [Scientific article]Open Access
Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica, Prostate cancer and novel pharmacological treatment options - what's new for 2022?, «EXPERT REVIEW OF CLINICAL PHARMACOLOGY», 2023, 1, pp. 1 - 14 [Scientific article]
Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco, Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [Scientific article]
Tateo, Valentina; Mollica, Veronica; Rizzo, Alessandro; Santoni, Matteo; Massari, Francesco, Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [Scientific article]
Santoni, Matteo; Myint, Zin W; Büttner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T; Gilbert, Danielle; Küronya, Zsófia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina-Cerrillo, Javier; Galli, Luca; Bamias, Aristotelis; De Giorgi, Ugo; Zucali, Paolo Andrea; Rizzo, Mimma; Seront, Emmanuel; Popovic, Lazar; Caffo, Orazio; Buti, Sebastiano; Kanesvaran, Ravindran; Kopecky, Jindrich; Kucharz, Jakub; Zeppellini, Annalisa; Fiala, Ondřej; Landmesser, Johannes; Ansari, Jawaher; Giannatempo, Patrizia; Rizzo, Alessandro; Zabalza, Ignacio Ortego; Monteiro, Fernando Sabino M; Battelli, Nicola; Calabrò, Fabio; Porta, Camillo, Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 72, pp. 2961 - 2970 [Scientific article]Open Access
Raschi E.; Comito F.; Massari F.; Gelsomino F., Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY, «IMMUNOTHERAPY», 2023, 15, pp. 85 - 91 [Scientific article]
Matteo Santoni; Javier Molina-Cerrillo; Giorgio Santoni; Elaine T. Lam; Francesco Massari; Veronica Mollica; Giulia Mazzaschi; Bernardo L. Rapoport; Enrique Grande; Sebastiano Buti, Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences, «CANCERS», 2023, 15, Article number: 408 , pp. 1 - 10 [Scientific article]Open Access
Monteiro, Fernando Sabino Marques; Fiala, Ondřej; Massari, Francesco; Myint, Zin W; Kopecky, Jindrich; Kucharz, Jakub; Büttner, Thomas; Grande, Enrique; Bourlon, Maria Teresa; Molina-Cerrillo, Javier; Pichler, Renate; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Bamias, Aristotelis; Bhuva, Dipen; Vau, Nuno; Porta, Camillo; Fay, Andre Poisl; Santoni, Matteo, Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study, «CLINICAL GENITOURINARY CANCER», 2023, 1, pp. 1 - 13 [Scientific article]
Melotti, Sofia; Ambrosi, Francesca; Franceschini, Tania; Giunchi, Francesca; Filippo, Giorgia Di; Franchini, Eugenia; Massari, Francesco; Mollica, Veronica; Tateo, Valentina; Bianchi, Federico Mineo; Colecchia, Maurizio; Acosta, Andres Martin; Lobo, João; Fiorentino, Michelangelo; Ricci, Costantino, TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 247, pp. 154540 - 154546 [Scientific article]Open Access
Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco, TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 253, pp. 155008 - 155013 [Scientific article]
Nuvola, Giacomo; Mollica, Veronica; Massari, Francesco; Suárez, Cristina, The future of immunotherapy in advanced renal cell carcinoma: beyond PD-1/PD-L1 inhibitors, «IMMUNOTHERAPY», 2023, 1, pp. 1 - 6 [Scientific article]
Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Tateo, Valentina; Tassinari, Elisa; Rosellini, Matteo; Massafra, Raffaella; Santoni, Matteo; Massari, Francesco, The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 1, pp. 1 - 11 [Scientific article]
Monteiro, Fernando Sabino Marques; Soares, Andrey; Rizzo, Alessandro; Santoni, Matteo; Mollica, Veronica; Grande, Enrique; Massari, Francesco, The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis, «CLINICAL GENITOURINARY CANCER», 2023, 23, pp. 1 - 10 [Scientific article]
